比马前列素植入剂长期降低眼压的机制探讨
本研究评估药理学相关浓度的比马前列素及比马前列素游离酸(BFA)对人房水流出组织细胞基质金属蛋白酶(MMP)基因表达的影响。比马前列素剂量依赖性上调MMP1、MMP14等基因,高浓度时效应显著;BFA仅上调MMP1至对照的2-3倍。作者认为高浓度比马前列素上调MMP1并下调纤连蛋白可能促进流出道重塑和长期眼压降低。
要点
- 比马前列素剂量依赖性上调小梁网、巩膜成纤维细胞和睫状肌细胞的MMP1和MMP14 mRNA。
- 正常眼小梁网细胞在1000微摩尔比马前列素时MMP1 mRNA均值达对照的62.9倍。
- BFA仅使小梁网和巩膜成纤维细胞MMP1 mRNA升至对照的2-3倍。
核心结论
- 比马前列素与BFA对MMP/ECM基因表达有不同效应。
- 高浓度比马前列素(植入眼内观察到的浓度)大幅上调MMP1并下调纤连蛋白,可能促进流出组织持续重塑和超出眼内药物生物利用度时间的长期眼压降低。
- 不同供体细胞株间比马前列素刺激的MMP上调存在变异,可能有助于解释患者对比马前列素植入剂长期反应的差异。
研究设计与样本
- 体外实验:采用聚合酶链反应阵列检测人小梁网、巩膜成纤维细胞和睫状肌细胞在比马前列素或BFA暴露后的MMP基因表达。
- 比马前列素浓度范围为10至1000微摩尔,BFA浓度范围为0.1至10微摩尔,分别对应眼内植入剂和局部滴眼后的眼内浓度。
- 正常眼小梁网细胞来源n=6,原发性开角型青光眼小梁网细胞来源n=3。
主要发现
- 比马前列素在所有细胞类型中剂量依赖性上调MMP1和MMP14 mRNA,并在小梁网和睫状肌细胞中上调MMP10和MMP11 mRNA。
- 正常眼小梁网细胞在1000微摩尔比马前列素时MMP1 mRNA平均水平为对照的62.9倍。
- BFA仅在小梁网和巩膜成纤维细胞中上调MMP1 mRNA至对照的2至3倍。
- 正常或原发性开角型青光眼眼小梁网细胞的ECM相关基因表达最大变化出现在1000微摩尔比马前列素时,阵列84个基因中有9-11个基因变化≥50%且具统计学显著性,而10微摩尔BFA仅1个基因变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to evaluate the effects of pharmacologically relevant bimatoprost and bimatoprost free acid (BFA) concentrations on matrix metalloproteinase (MMP) gene expression in cells from human aqueous outflow tissues. METHODS: MMP gene expression by human trabecular meshwork (TM), scleral fibroblast (SF), and ciliary muscle (CM) cells exposed to 10 to 1000 µM bimatoprost or 0.1 to 10 µM BFA (intraocular concentrations after intracameral bimatoprost implant and topical bimatoprost dosing, respectively) was measured by polymerase chain reaction array. RESULTS: Bimatoprost dose-dependently upregulated MMP1 and MMP14 mRNA in all cell types and MMP10 and MMP11 mRNA in TM and CM cells; in TM cells from normal eyes, mean MMP1 mRNA levels were 62.9-fold control levels at 1000 µM bimatoprost. BFA upregulated MMP1 mRNA only in TM and SF cells, to two- to three-fold control levels. The largest changes in extracellular matrix (ECM)-related gene expression by TM cells derived from normal (n = 6) or primary open-angle glaucoma (n = 3) eyes occurred with 1000 µM bimatoprost (statistically significant, ≥50% change for 9-11 of 84 genes on the array, versus 1 gene with 10 µM BFA). CONCLUSIONS: Bimatoprost and BFA had differential effects on MMP/ECM gene expression. Dramatic upregulation in MMP1 and downregulation of fibronectin, which occurred only with bimatoprost at high concentrations observed in bimatoprost implant-treated eyes, may promote sustained outflow tissue remodeling and long-term intraocular pressure reduction beyond the duration of intraocular drug bioavailability. Variability in bimatoprost-stimulated MMP upregulation among cell strains from different donors may help explain differential long-term responses of patients to bimatoprost implant.
引用
- Stamer WD, Perkumas KM, Kang MH, et al. Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant. Invest Ophthalmol Vis Sci. 2023. PMID: 36877514. doi:10.1167/iovs.64.3.15
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。